`______________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________________
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner
`
`v.
`NOVO NORDISK A/S,
`Patent Owner
`______________________
`Case IPR2023-00724
`Patent 10,335,462
`______________________
`
`NOTICE OF DEPOSITION OF JOHN BANTLE, M.D.
`
`
`
`
`
`IPR2023-00724
`U.S. Patent 10,335,462
`Pursuant to 37 C.F.R. §42.53, Patent Owner Novo Nordisk A/S (“Novo”), by
`
`and through its attorneys, will conduct cross-examination by deposition of John
`
`Bantle, M.D. Dr. Bantle’s deposition will take place on December 29, 2023,
`
`commencing at 9:00 AM CT/ 10:00 EST on each day, and continuing from day-to-
`
`day if necessary, via remote audio-video conference via a remote platform.
`
`The cross-examination will be taken before a Notary Public or other officer
`
`authorized by law to administer oaths. It will be recorded by using stenographic
`
`means or a digital reporter. Novo further reserves the right to utilize the following:
`
`(1) record the deposition using audio technology; (2) instant visual display such
`
`that the reporter’s writing of the proceeding will be available to all who are a party
`
`to this proceeding to request and receive it in real time; (3) exhibit capture
`
`(picture-in-picture) technology in which any exhibit reviewed by the deponent
`
`during the deposition can be captured visually; and (4) to conduct this deposition
`
`using a paperless exhibit virtual display platform. The arrangement for the reporter
`
`will be made by counsel for Novo.
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`2
`
`
`
`
`
`IPR2023-00724
`U.S. Patent 10,335,462
`Dated: December 15, 2023
`
`By: /Megan Raymond /
`
`J. Steven Baughman (Reg. No. 47,414)
`GROOMBRIDGE, WU, BAUGHMAN & STONE LLP
`801 17th Street, NW, Suite 1050
`Washington, DC, 20006
`P: (202)-505-5832
`steve.baughman@groombridgewu.com
`
`Megan Raymond (Reg. No. 72,997)
`GROOMBRIDGE, WU, BAUGHMAN & STONE LLP
`801 17th Street, NW, Suite 1050
`Washington, DC, 20006
`P: (202)-505-5878
`megan.raymond@groombridgewu.com
`
`Attorneys for Patent Owner Novo Nordisk A/S
`
`
`
`3
`
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2023-00724
`U.S. Patent 10,335,462
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of NOTICE OF DEPOSITION
`
`OF JOHN BANTLE M.D. has been served in its entirety by causing the
`
`aforementioned document to be electronically mailed to the following attorneys of
`
`record for Petitioner listed below:
`
`Petitioner’s Counsel of Record:
`
`Lead Counsel:
`
`Brandon M. White
`Reg. No. 52,354
`White-ptab@perkinscoie.com
`Perkins Coie LLP
`700 13th Street, NW
`Washington, DC 20005
`Telephone: (202) 654-6200
`
`By Electronic Mail
`Backup Counsel: Emily J. Greb
`Reg. No. 68,244
`Greb-ptab@perkinscoie.com
`Perkins Coie LLP
`33 East Main Street
`Madison, WI 53703
`Telephone: (608) 663-7460
`
`Courtney Prochnow, PhD
`Reg. No. 67,639
`Prochnow-ptab@perkinscoie.com
`Perkins Coie LLP
`633 W. 5th St., Ste 5850
`Los Angeles, CA 90071
`Telephone: (310) 788-9900
`
`Christopher D. Jones
`Reg. No. 76,472
`4
`
`
`
`
`
`
`
`
`
`
`
`IPR2023-00724
`U.S. Patent 10,335,462
`
`Jones-ptab@perkinscoie.com
`Perkins Coie LLP
`700 13th Street, NW
`Washington, DC 20005
`Telephone: (202) 654-6200
`
`Jonathan I. Tietz, PhD
`Reg. No. 76,753
`Tietz-ptab@perkinscoie.com
`Perkins Coie LLP
`700 13th Street, NW
`Washington, DC 20005
`Telephone: (202) 654-6200
`
`Matthew A. Lembo
`Reg. No. 75,633
`Lembo-ptab@perkinscoie.com
`Perkins Coie LLP
`1155 Avenue of the Americas
`Floor 22
`New York, NY 10036
`Telephone: (212) 262-6900
`
`Semaglutide-Ozempic@perkinscoie.com
`By Electronic Mail
`
`Dated: December 15, 2023
`
`
`
`Respectfully submitted,
`By: /Sayem Osman /
`Sayem Osman
`
`5
`
`